SINGAPORE, Oct. 13, 2025 -- PFPFA Singapore Pte Ltd ("PFPFA Singapore") hosted its annual Charity Night on 11 October 2025 at the Pan Pacific Singapore, announcing a $100,000 corporate donation to The Straits Times School Pocket Money Fund (STSPMF). In addition, a further $64,000 was raised during the event, reinforcing PFPFA's ongoing commitment to supporting children from low-income families through STSPMF's programmes and outreach efforts. Since its first Charity Night in 2007, PFPFA and its community of staff, wealth associates, associates, partners, and c
[ 메디채널 황정호 기자 ] WIP Capital Investments Pty Ltd (ACN 686 632 066) as trustee for WIP Capital Investments Trust (the Issuer) MELBOURNE, Australia, Oct. 13, 2025 -- The Issuer would like to offer institutions the opportunity to participate as a noteholder under a loan note deed poll, dated as of 27 May 2025, as amended from time to time (the Loan Note Deed) in respect of notes to be issued by the Issuer under the Loan Note Deed, as described in more detail in the commercial terms sheet attached to this offer letter (the Notes). The proceeds of the Notes will be used by the Issuer to, a
CHANGSHA, China, Oct. 13, 2025 -- This is a report from Hunan Today: At the foot of Yuelu Mountain, Yuelu Academy's red gate stands with the old couplet "Only Chu Has Talents, and Here They Shine Most." Two young women in Hanfu—Ying and Shi—met American scholar Professor Xia (who's studied Hunan culture for 7 years) here. Xia explained the couplet's meaning and shared the academy's history: it's 300 years older than Oxford, and great minds like Zhu Xi and Mao Zedong once sought truth here. Ying asked Xia to guide them, and he agreed, changing into a scholar's robe. As an
SHANGHAI, Oct. 13, 2025 -- Smartee Denti-Technology today announced the global launch of the Smartee Sleep Aligners, a clear aligner device designed to help manage obstructive sleep apnoea hypopnoea syndrome (OSAHS) and primary snoring (PS). The new series includes two versions: Smartee SA, which focuses on the treatment of OSAHS and PS, and Smartee SA Plus. The latter can treat OSAHS while simultaneously addressing orthodontic issues. Together, they provide clinicians with an invisible alternative to conventional OSAHS treatment therapies, offering greater comfort and compliance, and improvi
SINGAPORE, Oct. 13, 2025 -- Carlsberg Asia and Grab, Southeast Asia's leading superapp, celebrated the second year of their strategic partnership on September 18, coinciding with Global Beer Responsible Day — an alliance that continues to reshape how consumers experience beer across the region. Launched in Q4 2024, the collaboration brings together digital innovation, premium beer experiences and enhanced consumer reach. In addition, both companies reinforced their shared commitment to promoting safe and responsible consumption across the region. Rooted in a shared vision to champion m
SINGAPORE, Oct. 13, 2025 -- Concert travel is reshaping tourism in Asia, with fans crossing borders and booking trips to see the artists they love. Trip.com Group, a global leader in travel services, and Live Nation Asia, the world's leading live entertainment company, have announced a multi-year strategic partnership to integrate travel and live music experiences across key Asian markets. Launching across Hong Kong/Macau, Singapore, Thailand, South Korea and Mainland China, the collaboration will allow fans to seamlessly plan concert-focused trips — combining exclusive
[ 메디채널 김갑성 기자 ] EVM14 becomes Everest Medicines' internally developed therapeutic mRNA cancer vaccine to receive IND approvals from both China's National Medical Products Administration (NMPA) and the U.S. Food and Drug Administration (FDA). EVM14, an off-the-shelf therapeutic mRNA cancer vaccine, is developed based on Everest Medicines' proprietary mRNA platform. It is formulated with mRNA encoding 5 tumor-associated antigens (TAAs) and is designed to treat various squamous cell carcinomas. In preclinical studies, EVM14 demonstrated the ability to induce immune memory and prevent tumor
- In head-to-head non-human primate (NHP) studies, average observed half-life of ASC35 was approximately 14 days, 6-fold longer than tirzepatide, which supports once-monthly subcutaneous (SQ) dosing in humans. - In head-to-head NHP studies, drug exposures of ASC35 intravenous (I.V.) and SQ administration were approximately 80% and 70% greater than tirzepatide I.V. and SQ administration, respectively. - ASC35 was approximately 4-fold more potent than tirzepatide for both GLP-1 receptor (GLP-1R) and GIP receptor (GIPR) in vitro. - ASC35 demonstrated approximately 71% greate
Advancing regional collaboration and surgeon training in remote robotic-assisted surgery SINGAPORE, Oct. 13, 2025 -- Reach Surgical, the Surgical Solutions division of Genesis MedTech, has facilitated the completion of two robotic telesurgeries using its OMNIBOT robotic-assisted system. Operating from Reach Surgical Institute (RSI) in Santiago, Dr. Roberto Vilches and Dr. Marcelo Kerkebe remotely performed a radical prostatectomy and a partial nephrectomy on patients at Meds Medical Center. These procedures mark an important milestone in advancing robotic t
リモージュ(フランス), 2025年10月13日 -- 1824年創業の象徴的なリモージュ磁器メーカーJL Coquetは、TVS Venu International Holdings Pte Ltdが新たに設立したAtelier Expressionsへの参画により、歴史の新たな章を開きます。シンガポールに拠点を置くAtelier Expressionsは、卓越した企業と伝統的技術の継承を推進することを目的としています。 この戦略的提携は、特に白磁の卓越性で知られる同メーカーにとって大きな前進となります。これは国際展開と職人技の振興への取り組みの一環であり、専門技術の継承とメーカー内での雇用維持に重点を置いています。 「JL Coquetの作品は時代を超えた伝統と完璧な職人技を体現しており、常に感銘を受けてきました」と、Atelier Expressionsのエグゼクティブ・ディレクター、Tara S. Venu氏は述べています。「今回の買収がもたらす可能性に胸を躍らせています。JL Coquetの精神は、卓越した品質と職人技を体現する企業に国際的な認知をもたらすという我々の志と完全に一致しています。」 Sébastien Cich氏がチームと製造スタッ